Publications by authors named "Ahlim Alsanani"

Hepatitis B-associated glomerulonephritis (GN) has been recognized for decades. However, only a few cases of IgA nephropathy (IgAN) in a setting of rapidly progressive glomerulonephritis (RPGN) associated with chronic hepatitis B virus (HBV) have been described. Herein, we report the case of a 42-year-old Asian female with a past medical history significant for chronic HBV on entecavir, hypertension, chronic kidney disease, and newly diagnosed breast cancer, who underwent elective bilateral mastectomy and breast augmentation.

View Article and Find Full Text PDF

Objective: The triad of obesity, a high-protein diet from animal sources, and disturbed gut microbiota have been linked to poor clinical outcomes in patients with COVID-19. In this report, the effect of oxidative stress resulting from the Na /K -ATPase transporter signaling cascade is explored as a driver of this poor clinical outcome.

Methods: Protein-protein interactions with the SARS-CoV-2 proteome were identified from the interactome data for Na /K -transporting ATPase subunit α-1 (ATP1A1), epidermal growth factor receptor, and ERB-B2 receptor tyrosine kinase 2, using the curated data from the BioGRID Database of Protein Interactions.

View Article and Find Full Text PDF

Viral infections in the immunocompetent host can cause both acute and chronic kidney disease either as a direct damage to the infected kidney cells or as a consequence of systemic immune responses that impact kidney function. Since identifying these entities in the 1970s and 80s, major breakthroughs in the understanding of the viral mechanisms have occurred. Viruses have evolved mechanisms to hijack signaling pathways of infected cells to evade antiviral immune responses by the host.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates kidney biopsies with diffuse monoclonal light chain staining, highlighting the challenges in diagnosing MIg-associated kidney disease, as findings can vary significantly and lead to misdiagnosis or unnecessary treatment.* -
  • Out of 32 cases analyzed, nearly half (47%) had active myeloma requiring immediate treatment, while some patients showed no myeloma, illustrating the complexity of interpreting biopsy results.* -
  • The authors stress the need for detailed hematologic evaluations and recommend ongoing monitoring to identify any malignant changes while avoiding inappropriate treatments for patients without active myeloma.*
View Article and Find Full Text PDF